U.S. Capital Wealth Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-23,061
| Closed | -$2.38M | – | 684 |
|
2023
Q3 | $2.38M | Buy |
23,061
+7,893
| +52% | +$815K | 0.11% | 173 |
|
2023
Q2 | $1.84M | Buy |
15,168
+10,155
| +203% | +$1.23M | 0.09% | 225 |
|
2023
Q1 | $770K | Buy |
5,013
+2,199
| +78% | +$338K | 0.04% | 349 |
|
2022
Q4 | $505K | Sell |
2,814
-550
| -16% | -$98.8K | 0.02% | 449 |
|
2022
Q3 | $398K | Buy |
3,364
+250
| +8% | +$29.6K | 0.02% | 480 |
|
2022
Q2 | $445K | Sell |
3,114
-164
| -5% | -$23.4K | 0.02% | 489 |
|
2022
Q1 | $565K | Buy |
+3,278
| New | +$565K | 0.02% | 487 |
|